Vuno 

Vuno Inc. specializes in developing artificial intelligence solutions for the medical industry. The company's AI-driven offerings are designed to analyze diverse medical data, providing crucial assistance in diagnosing various diseases. Its comprehensive product suite includes BoneAge, an AI software for assessing bone age; DeepBrain, a quantitative brain parcellation tool for analyzing neurodegenerative and other neurological conditions; an AI-powered diagnostic support system for detecting abnormalities in chest X-rays; Fundus AI, an AI-based screening solution for retinal irregularities; and LungCT AI, which focuses on detecting and reporting pulmonary lung nodules. Established in 2014, the company is headquartered in Seoul, South Korea.